
BIOS Health
BIOS Health is a YC Winter 2017 (W17) company. Based in Cambridge, England, United Kingdom; England, United Kingdom. Team of 45.
About BIOS Health
Summary
BIOS Health builds neural interface hardware and AI software that reads and writes signals carried by the peripheral nervous system, giving researchers and clinicians real-time access to the body's neural data. The platform serves pharmaceutical and medical-device developers who need precise, data-driven insight into how nerves govern organ function and disease. It replaces blunt, trial-and-error approaches to neuromodulation and drug development with closed-loop, signal-level feedback from the nervous system.
Go-to-market
BIOS targets pharmaceutical companies and medical researchers through partnerships, providing its neural interface and AI platform as the underlying infrastructure for developing new neural digital therapies and drug candidates.
From the Y Combinator listing
Neural interfaces to understand and use nerve data in medicine.
BIOS Health was previously called Cambridge Bio-Augmentation Systems (CBAS) and focused on prosthetic neural interfaces as a first market. Now we use
Facts
- Healthcare / Healthcare
- Cambridge, England, United Kingdom; England, United Kingdom
- 45
- Active
- Early
Founders (2)
- Emil Hewage
- Oliver Armitage
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works